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ABSTRACT 
Viral hepatitis poses a serious threat to mankind. Hepatitis B and C Virus are blood borne 
pathogens that affect millions of individually globally. This study was conducted on a hospital-
based population in Islamabad, Pakistan over a period of 4 months, utilizing ELISA as the 
diagnostic technique which suggested a higher seroprevalence rate for both HBV and HCV i.e. 
2.07% and 8.24% respectively. A correlational analysis of the biochemical parameters of these 
individuals with HBV and HCV infection was carried out and the results indicated a positive 
correlation of HBV with Alkaline Phosphatase (ALP), HCV with Total Bilirubin (TBil) and 
both the viruses with Alanine Aminotransferase (ALT). Furthermore, the risk factors in relation 
to these viral infections were explored upon which our data suggested that surgery, blood 
transfusion and contact with contaminated instruments at the barber for haircut/shaving and 
jewelers for piercings were the major risk factors responsible for aiding the contraction of the 
viral disease by patients in the hospital. These high percentages of the viral infection among 
the population require proper management and prevention techniques to minimize the number 
of casualties and further cases to provide a healthier surrounding for the people to live in.  
Keywords: HBV, HCV, seroprevalence, biochemical investigation, risk factor.  
INTRODUCTION 
Hepatitis is a global health problem. 
In 2017, 1.3 million people died with viral 
hepatitis (Roth et al., 2018). Liver 
inflammation is a lethal hepatic 
abnormality caused due to either viral or 
non-viral factors that tends to progress 
towards cirrhosis and hepatocellular 
carcinoma (HCC) (Karim et al., 2015; Zhu 
et al., 2008). Hepatitis B & C Viruses are 
blood borne pathogens belonging to family 
Hepadnaviridae and Flaviviradae, 
containing dsDNA with genome of 3.2 kb 
and ssRNA with genome of 9.6 kb 
respectively (Seeger and Mason, 2000; 
Torres et al., 2013; Catanese et al., 2013). 
Both HBV and HCV show great tropism 
towards hepatocytes. Globally, the chronic 
infection rate observed for HBV and HCV 
is 257 million and 150 million respectively 
with a mortality rate of 720,000 was 
observed owing to cirrhosis and 470,000 
due to hepatocellular carcinoma 
collectively caused by HBV and HCV 
(Alam et al., 2007; Schweitzer et al., 2015; 
World Health Organization, 2017).  
Despite the availability of 
immunogenic, anti-viral and effective 
vaccines (for HBV), statistics show that 
350-400 million people are carriers of 
HBV. Appropriate clinical manifestation is 
required to distinguish between HBV 
infection from other hepatitis causing 
viruses (World Health Organization, 2017; 
Datta et al., 2012). Different molecular and 
routinely performed serological assays like 
PCR, qPCR, Competitive PCR, ICT and 
ELISA are used for the quantification of 
HBV and HCV (Aguiar et al., 2014; 
Pawlotsky et al., 2002; Lok and McMahon 
2007; Rahman et al., 2008).  
Along with molecular and 
serological methods different biochemical 
Rana et al. (2020). Biochemical Investigation and Risk Factor Assessment for HBV & HCV Infection 
J Biores Manag. 7 (2): 10-18 
11 
 
markers are involved to determine hepatic 
function in case of hepatitis. Among these 
marker ALT, AST, ALP, albumin and 
bilirubin are considered vital for the 
assessment of hepatic function in the blood 
of infected individual (Chen et al., 2014; 
Pattullo, 2015; Sharif et al.,2016; 
Locasciulli et al., 1993; El-Kady et al., 
2017). It was noted that in chronic liver 
infection, the level of ALT increased due to 
parenchymal hepatic cell damage and 
excessive leakage of the enzyme into blood 
stream was observed. In patients with 
untreated chronic infection, the increase of 
ALT levels up to 400UI/L was observed 
(Olut et al., 2007; Mohamadnejad et al., 
2003; Khan et al., 2016). Another important 
biochemical marker involved in 
metabolism and transportation of 
metabolites across the membranes is ALP. 
Studies show that the cholestatic liver 
diseases cause more release of this enzyme 
and increase serum ALP level in chronic 
hepatitis (Pattullo, 2015; Sleisenger et al., 
1998; Whitehead et al., 1999). The level of 
these biochemical markers on individual 
basis or in combination help to determine 
the hepatic function in viral hepatic 
diseases.  
It has been observed through 
different studies that multiple risk factors 
are involved in the viral transmission. 
Different factors like mother’s age, number 
of pregnancies, repeated injection, 
addiction and history of blood transfusion 
could be involved in vertical transmission 
of hepatitis B & C from mother to infant 
(Mehnaz et al., 2002; Fauteux-Daniel et al., 
2017). Risk factors which are the main 
source of hepatitis transmission include 
blood transfusion/transmission, dialysis, 
reuse of needles for ear and nose piercing, 
reuse of syringes, tattooing, shaving/cuts 
from barbers and the usage of unsterilized 
dental and surgical instruments (Idrees et 
al., 2011; Bukhari et al., 1999; Waheed et 
al., 2009). Intravenous drug abuse is also 
considered to be one of the most pivotal risk 
factors for causing Hepatitis B or C 
infection (Kazi et al., 2010; Fayyaz et al., 
2006; Chen and Morgan, 2006). 
Pakistan is a developing country 
with low investments on health It has been 
estimated that approximately 32% of the 
Pakistani population is exposed to HBV 
with 2-4% chronic HBV prevalence rate 
and 10% of the population suffers from 
HCV infection with approximately 4.5-
8.2% seroprevalence in adult population 
(Khan et al., 2011; Waheed et al., 2018; 
Iqbal et al., 2014; Umer and Iqbal 2016).  
 There is a strong need to do 
research on hepatitis B and C in Pakistan. 
The purpose of the present study was to find 
the seroprevalence of HBV and HCV 
infections among the population of twin 
cities, the risk factors associated with these 
viral infections and to find the correlation 
between Hepatitis B and C Sero-positivity 
with commonly measured liver 
biochemical markers.  
 
MATERIALS AND METHOD 
Sample Collection and Processing 
A total of 1977 blood samples were 
collected from Capital Development 
Authority (CDA) Hospital Islamabad from 
June-October 2018. Blood (3-5 ml) was 
collected via venipuncture technique and 
stored in vacutainer tubes with clot 
activator to produce serum upon 
centrifugation. The samples were 
centrifuged right after collection at 5000 
rpm for 5 min to obtain serum which was 
then separated using filter tips. Each serum 
sample was divided into two parts each for 
both serological and biochemical testing.  
Serological Testing 
The serum samples were 
qualitatively tested against HBsAg 
(Hepatitis B surface antigen) and Anti-
HCV antibodies through rapid diagnostic 
test i.e. Immunochromatographic test (ICT) 
followed by ELISA-based confirmation 
automated Vitros®Eciq Immunodiagnostic 
Analyzer Biochemical Analysis. For 
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quantification of liver specific enzymes, 
centrifuged serum samples of HBV and 
HCV screened patients were subjected to 
Liver function tests (LFTs) and Renal 
function tests (RFTs). Biochemical analysis 
was performed in Selectra XL analyzer. 
Data Analysis 
To find an association between 
HBV and HCV serological positivity with 
liver enzyme abnormalities, Pearson`s 
correlation test was run, where the (p-value) 
less than 0.05 with confidence interval of 
95% was considered statistically 
significant.  
RESULTS 
Seroprevalence of HBV and HCV Based 
on ELISA 
Serum from the blood samples of 
1977 patients was initially screened by ICT 
method followed by confirmation with 
enzyme-linked immunosorbent assay 
(ELISA) for the detection of HBsAg and 
anti-HCV antibodies. The results revealed 
that 40/1977 (2.07%) patients tested 
positive for Hepatitis B Virus and 163/1977 
(8.24%) of the patients tested positive for 
Hepatitis C Virus in their serum (Figure 1). 
 
 
Figure 1: Seroprevalence of HBV and HCV 
among hospital-based patients.   
  
Gender-Wise Distribution of HBV and 
HCV Infection 
Out of the 1977 patients subjected 
to screening for HBV and HCV, 50.32% of 
the patients were male and 49.67% were 
female. Whereas the patients screened for 
HCV were 45.22% male and 54.77% 
female. The data suggests that 2.7% of the 
males and 1.3% of the females were 
positive for HBV infection. Whereas 7.24% 
males and 9.04% females were positive for 




Figure 2: Gender based Seroprevalence of HBV 
and HCV. 
 
Age-Wise Distribution of HBV and HCV 
Infection 
The patients who tested positive for 
HBV or HCV in their serum were divided 
into seven age groups. The minimum age 
group was kept at <20 years and the 
maximum was kept at >70 years. The rate 
of infection was seen to be the highest 
among the individuals from the age group 
61-70 years. Based on this data, a range of 
age-wise frequency distribution has been 
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Figure 3: Age-wise distribution of HBV and 
HCV infected patients among hospital-based 
patients. 
 
Correlational Analysis of HBV and HCV 
Groups  
Using Pearson Product Moment 
Correlation, the relationship of the HBV 
and HCV positive and negative participants 
with the variables under study was 
analyzed. Results of the correlational 
analysis suggested that HBsAg sero-
postivity was significantly associated with 
abnormal levels of Hepatic enzymes 
(Alanine Aminotransferase) ALT and 
(Alkaline Phosphatase) ALP (p<0.05) 
whereas HCV sero-positivity showed a 
significant and positive correlation with the 
increased levels of the hepatic enzymes 
ALT and Total Bilirubin  (p<0.05) (Table 
1). 
Risk Factor Analysis  
In the study sample, the patients 
who tested positive for HBV and HCV in 
their serum showed multiple risk factors 
responsible for rendering them more 
susceptible to infection. Except for a few, 
most of the risk factors for contracting HBV 
and HCV were the same, for both the 
viruses are blood-borne. The risk factors 
included general surgery, dental surgery, 
blood transfusion and donation, pregnancy, 
tattoo formation, nose and ear piercing, cuts 
from barber shop equipment etc. The 
highest prevailing risk factor among the 
Hepatitis B Virus infected individuals in the 
sample was nose and ear piercing whereas 
among the Hepatitis C Virus infected 
individuals was general surgery (Figure 4). 
Fig.4: Risk factors observed among the positive 
patients of HBV and HCV. 
  
DISCUSSION 
Prevalence   
As per the findings of this study, the 
seroprevalence of Hepatitis B Virus among 
the patients who visited the hospital facility 
of Rawalpindi-Islamabad for treatment or 
diagnosis was calculated to be 2.02% and in 
case of Hepatitis C Virus, it was calculated 
to be 8.24%. Numerous studies have been 
conducted worldwide to observe the 
prevalence of hepatic viruses to resolve the 
epidemiological concerns. Our results were 
supported by the study conducted by Haider 
et al. (2017) which showed that the 
prevalence of HBsAg+ among their sample 
was 2.14%. The research conducted by 
Muzaffar et al. (2016) indicated the 
prevalence of HCV to be 5.31% among the 
population of the twin cities and other 
additional studies carried out in different 
regions of the country showed various 
results such as Lahore (4.94%) (Anwar et 
al., 2013) and Mansehra (7.0%) (Ali et al., 
2010). The difference between the 
prevalence of HCV in the current study and 
other respective studies mentioned above 
may have occurred since data collection 
and sample screening in this study was done 
at a hospital facility with people visiting 
either for treatment or diagnosis. 
It was seen that in case of HBV 
infection, the percentage of male cases was 
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higher than female cases which is supported 
by the findings of other studies (Naz et al., 
2002; Khan et al., 2011). A possible cause 
for the larger percentage of males being 
infected is their frequent visits to the barber 
shop and direct contact with contaminated 
instruments used for grooming. The 
number of females who tested positive for 
HCV infection was higher than males 
because the patients from the gynae ward 
paid more frequent visits to the hospital 
facility where the data collection was 
carried out.  
Considering the age-wise 
distribution of viral hepatitis cases caused 
by Hepatitis B and C in the current study, 
the maximum number of cases were seen in 
the age group (61-70 years). This finding 
was supported by the survey conducted by 
(Ali et al., 2008) which showed that the 
maximum number of infected individuals 
were above 60 years of age. The saturation 
of cases in this age group can be since old 
age brings along consequences such as 
weakened immune system and it can render 
the individual more susceptible to 
contraction of the viral disease.  
Biochemical Analysis  
In the current study, the 
correlational analysis of viral hepatitis with 
different biochemical parameters which 
included ALT, ALP, Total Bilirubin and 
creatinine was carried out. A positive and 
significant correlation was observed 
between both HBV and HCV with ALT, 
where (p<.05), similar results were 
obtained by other studies (Mastoi et al., 
2010; Wahib et al., 2006), where ALT 
levels increased significantly among the 
HCV infected patients. Also, elevation in 
serum ALT levels was seen among patients 
suffering from chronic hepatitis B infection 
(Liaw et al., 2005). The requirement of 
ALT for the synthesis reactions in the liver 
are the cause for its quantity to be around 
3000 times higher than the serum and this 
becomes the reason for ALT to be a marker 
for liver damage. When hepatocellular 
injury or death is concerned, ALT seeps out 
from the damaged cells in to the serum and 
ultimately, it is detected upon testing (Kim 
et al., 2008). 
Hepatitis B Virus showed a positive 
and significant correlation with ALP and 
Hepatitis C Virus with Total Bilirubin, 
where (p<.05). These findings were 
corroborated by the research carried out by 
Abulude et al. (2017), the results of which 
showed elevated ALP levels among their 
sample i.e. HBV positive patients. High 
levels of ALP can be seen due to blockage 
along the biliary tract (biliary obstruction) 
or pressure build up in the liver due to 
scarring which can, but do not necessarily 
indicate a viral infection. A study was 
carried out to investigate similar parameters 
and elevated levels of Total Bilirubin were 
seen among 35% of their study sample 
which was infected by HCV (Wahib et al., 
2006). The results of another study by (Ijaz 
et al., 2011) showed elevated levels of 
bilirubin among patients infected with 
Hepatitis C Virus (Genotype 4) as well. 
Hyperbilirubinemia is directly related to 
viral infection and the extent to which 
histological injury of hepatocytes has 
occurred (Thapa et al., 2007). Liver being 
the detoxifying organ of the body clears 
away the bilirubin produced upon 
breakdown of RBCs and due to scarring, it 
is unable to carry out this function and thus 
bilirubin levels increase within the serum 
(Limdi and Hyde, 2003). 
Risk Factor Analysis 
In the current study, the highest 
number of HBsAg seropositive patients in 
case of females were those had their ears or 
nose pierced and came in contact with 
contaminated instruments where as in case 
of males were the patients who paid 
frequent visits to the barbershops using un-
hygienic grooming instruments. Similar 
findings were observed by other studies 
(Yousfani et al., 2006; Asia et al., 2008) 
where piercings were the main risk factor 
for HBV transmission amongst females and 
frequent trips to barber shops using 
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contaminated instruments in males and 
children.   
The risk factors which were seen to 
be highly prevalent among the HCV sero-
positive patients in the current study were 
general surgery, blood donation & 
transfusion where the individuals had direct 
exposure to contaminated blood products or 
surgical instruments. A previous research 
corroborates the findings of this study and 
reported the population of Pakistan to be at 
a very high risk of developing an HCV 
infection through blood and blood-borne 
products due to unsafe medical procedures, 
lack of awareness, weak commitment to a 
safe environment, and illiteracy (Janjua et 
al., 2005).  
In this study, 7.97% of the pregnant 
female patients tested positive for the virus 
in their bloodstream. This finding was 
corroborated by the study conducted by 
Arshad and Ashfaq (2017) who observed 
that pregnant females contributed to 4.65% 
of their sample infected with the virus. 
Previous studies have indicated injectable 
drug users (IDUs) to be at the highest risk 
of developing Viral Hepatitis (Kuo et al., 
2006; Arshad and Ashfaq, 2017). However, 
the sample under study for this research 
didn’t have any IDUs due to the setting 
where the sample collection was done i.e. 
the out-patients department (OPD) at the 
Capital Development Authority (CDA) 
Hospital, Islamabad.  
CONCLUSION 
The serological prevalence of Hepatitis B 
and C virus among the population of 
Rawalpindi/Islamabad who visited the 
hospital for treatment or diagnosis was 
high, which is an alarming situation for the 
residents of the region. The age groups of 
the infected patients ranged from 15 – 70 
years. The individuals who were at a high 
risk of acquiring the infection included 
people who had undergone surgical 
procedures, blood transfusions, gotten nose 
and ear piercings, pregnant women and 
patients undergoing dialysis. Awareness 
campaigns to educate people about the 
transmission of viral hepatitis and to warn 
them regarding the threat it poses to 
people’s lives and the lives of those living 
among them must be organized.  Measures 
to eliminate the spread of this disease must 
be taken. The biochemical markers of 
Hepatitis B and C Virus in correlation with 
the infection yielded results which showed 
a positive and significant correlation among 
three of the markers. This aspect of the 
current study needs to be further 
investigated for this field needs further 
probing to provide the required information 
for treatment and better understanding. 
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